News
New CVS Health initiative seeks to solve one of the nation’s most pressing problems and a major source of consumer financial worry Recognizing the threat of rising drug prices and high out-of-pocket ...
Aetna is committed to making it easier to navigate health care — reducing reviews, simplifying care site transitions and using technology.
Weight management drugs can be strongly effective in helping to improve the health of people living with obesity or other weight-related health issues. However, drug manufacturers are solely ...
Full Year and Fourth Quarter Highlights: Full year total revenues increased to $268.7 billion, up 4.6% compared to prior year Full year and fourth quarter GAAP diluted earnings per share from ...
View earnings infographic (PDF) Visit Investor Relations for more about Q4 2021 earnings WOONSOCKET, Rhode Island — CVS Health Corporation (NYSE: CVS) today announced operating results for the three ...
Signify Health is a leading technology and services company, focused on provider enablement and bringing clinicians into the home to identify chronic conditions, close gaps in care, and address social ...
CVS Pharmacy® participated in a bankruptcy court approved bidding process and has agreed to acquire the prescription files of 625 Rite Aid pharmacies across 15 states in areas that CVS serves, as well ...
WOONSOCKET, R.I., May 2, 2023 — CVS Health® (NYSE: CVS ) today announced it has completed its acquisition of Oak Street Health. The acquisition will broaden CVS Health’s value-based primary care ...
Backed by the strength of CVS Health WOONSOCKET, R.I., Oct. 1, 2024 — Aetna®, a CVS Health® company (NYSE: CVS ), today announced our 2025 Medicare products bring together what matters most to our ...
CVS Health Appoints David Joyner President and Chief Executive OfficerRoger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted ...
At its 2023 Investor Day, CVS Health® shares how its strategy and combination of assets drives reliable, diversified, and accelerating earnings growth, while also delivering superior care and value to ...
The Cordavis products will be FDA approved, high quality and easy for patients to use and will help ensure consistent long-term supply of affordable biosimilars.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results